Journal article

Marked, Homogeneous, and Early [F-18]Fluorodeoxyglucose-Positron Emission Tomography Responses to Vemurafenib in BRAF-Mutant Advanced Melanoma

Grant A McArthur, Igor Puzanov, Ravi Amaravadi, Antoni Ribas, Paul Chapman, Kevin B Kim, Jeffrey A Sosman, Richard J Lee, Keith Nolop, Keith T Flaherty, Jason Callahan, Rodney J Hicks

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2012

Grants

Awarded by Victorian Cancer Agency


Awarded by National Health and Medical Research Council


Funding Acknowledgements

Supported by Plexxikon and Hoffman-La Roche and in part by Grants No. EOI09_27 from the Victorian Cancer Agency and APP1002655 from the National Health and Medical Research Council and by the Cancer Council of Victoria and the Sir Edward Weary Dunlop Clinical Research Fellowship from the Cancer Council of Victoria.Research Funding: Grant A. McArthur, Pfizer; Paul Chapman, Hoffman-La Roche/Genentech; Kevin B. Kim, Roche; Jeffrey A. Sosman, Bristol-Myers Squibb, GlaxoSmithKline